Abstract
The emerging field of targeted therapy is ushering in a new era of targeted/functional imaging, which compliments and sometimes improves upon traditional anatomic imaging for diagnosis, early assessment of treatment response, and estimation of durability of therapeutic success. Targeted/functional imaging has already had an impact on clinical management. With such methods, one may either measure the target directly or assess downstream effects. The former may provide greater specificity, whereas, the latter may have broader applicability. The clinical question will guide selection between the two. The primary modalities currently used clinically include nuclear medicine techniques, such as planar or single photon emission computed tomography or positron emission tomography, and MR based techniques, such as dynamic contrast enhanced MR imaging. An understanding of the physics and clinical applications of targeted/functional imaging and their requisite molecular imaging agents aides image interpretation. Combining such imaging with anatomic imaging is often advantageous. For the future, clinical trials of targeted/functional imaging are needed in addition to and in parallel with clinical trials of targeted therapeutics given the obvious synergy between the two.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ratain MJ. Clin Cancer Res 2005;11:5661–2.
Goffin J, Baral S, Tu D, et al. Clin Cancer Res 2005;11:5928–34.
Shepherd FA, Rodrigues Pereira J, et al. N Engl J Med 2005;353:123–32.
Thatcher N, Chang A, Parikh P, et al. Lancet 2005;366:1527–37.
Stroobants S, Goeminne J, Seegers M, et al. Eur J Cancer 2003;39:2012–20.
Shankar S, van Sonnenberg E, Desai J, et al. Radiology 2005;235:892–8.
Jerusalem G, Hustinx R, Beguin Y, et al. Semin Nucl Med 2005;35:186–96.
Torizuka T, Zasadny KR, Kison PV, et al. J Nucl Med 2000;41:999–1005.
Dehdashti F, Flanagan FL, Mortimer JE, et al. Eur J Nucl Med 1999;26:51–6.
Kluxen FW, Bruns C, Lubbert H. Proc Natl Acad Sci U S A 1992;89:4618–22.
Bell GI, Reisine T. Trends Neurosci 1993;16:34–8.
Panetta R, Greenwood MT, Warszynska A, et al. Mol Pharmacol 1994;45:417–27.
O’Carroll AM, Lolait SJ, Konig M, et al. Mol Pharmacol 1993;44:1278.
Yamada Y, Reisine T, Law SF, et al. Mol Endocrinol 1992;6:2136–42.
Termanini B, Gibril F, Reynolds JC, et al. Gastroenterology 1997;112:335–47.
Lamberts SW, Hofland LJ, Nobels FR. Front Neuroendocrinol 2001;22:309–39.
Kwekkeboom D, Krenning E, de Jong M. J Nucl Med 2000;41:1704–13.
Plonowski A, Schally AV, Nagy A, et al. Cancer Res 2000;60:2996–3001.
Schally AV, Nagy A. Eur J Endocrinol 1999;141:1–14.
Kwekkeboom DJ, Bakker WH, Kooij PP, et al. Eur J Nucl Med 2001;28:1319–25.
Linden HM, Stekhova SA, Link JM, et al. J Clin Oncol 2006;24:2793–9.
Wiseman GA, Kornmehl E, Leigh B, et al. J Nucl Med 2003;44:465–74.
Wahl RL. Semin Oncol 2003;30:31–8.
Yamane T, Daimaru O, Ito S, et al. J Nucl Med 2004;45:1838–42.
Su H, Bodenstein C, Dumont RA, et al. Clin Cancer Res 2006;12:5659–67.
Romer W, Hanauske AR, Ziegler S, et al. Blood 1998;91:4464–71.
Brepoels L, Stroobants S, Verhoef G. Leuk Lymphoma 2007;48:270–82.
Wahl RL, Zasadny K, Helvie M, et al. J Clin Oncol 1993;11:2101–11.
Mortimer JE, Dehdashti F, Siegel BA, et al. J Clin Oncol 2001;19:2797–803.
Weber WA, Wieder H. Eur J Nucl Med Mol Imaging 2006;33(suppl 1):27–37.
Cachin F, Prince HM, Hogg A, et al. J Clin Oncol 2006;24:3026–31.
Zijlstra JM, Lindauer-van der Werf G, Hoekstra OS, et al. Haematologica 2006;91:522–9.
Zijlstra JM, Hoekstra OS, Raijmakers PG, et al. Br J Haematol 2003;123:454–62.
Tsukamoto N, Kojima M, Hasegawa M, et al. Cancer 2007;110:652–9.
Shankar LK, Hoffman JM, Bacharach S, et al. J Nucl Med 2006;47:1059–66.
Huang SC. Nucl Med Biol 2000;27:643–6.
Yang D, Han L, Kundra V. Radiology 2005;235:950–8.
Antoch G, Kanja J, Bauer S, et al. J Nucl Med 2004;45:357–65.
Swisher SG, et al. Cancer 2004;101(8):1776–85.
Smyczek-Gargya B, Fersis N, Dittmann H, et al. Eur J Nucl Med Mol Imaging 2004;31:720–4.
Van Westreenen HL, Cobben DC, Jager PL, et al. J Nucl Med 2005;46:400–4.
Buck AK, Halter G, Schirrmeister H, et al. J Nucl Med 2003;44:1426–31.
Yap CS, Czernin J, Fishbein MC, et al. Chest 2006;129:393–401.
Dittmann H, Dohmen BM, Paulsen F, et al. Eur J Nucl Med Mol Imaging 2003;30:1407–12.
Muzi M, Vesselle H, Grierson JR, et al. J Nucl Med 2005;46:274–82.
Troost EG, Vogel WV, Merkx MA, et al. J Nucl Med 2007;48:726–35.
Buck AK, Hetzel M, Schirrmeister H, et al. N. Eur J Nucl Med Mol Imaging 2005;32:525–33.
Galldiks N, Kracht LW, Burghaus L, et al. Eur J Nucl Med Mol Imaging 2006;33:516–24.
Brock CS, Young H, O’Reilly SM, et al. Br J Cancer 2000;82:608–15.
Eschmann SM, Paulsen F, Reimold M, et al. J Nucl Med 2005;46:253–60.
Rischin D, Hicks RJ, Fisher R, et al. J Clin Oncol 2006;24:2098–104.
Gonzalez J, Kumar AJ, Conrad CA, et al. Int J Radiat Oncol Biol Phys 2007;67:323–6.
Batchelor TT, Sorensen AG, di Tomaso E, et al. Cancer Cell 2007;11:83–95.
Bastin ME, Sinha S, Whittle IR, et al. Neuroreport 2002;13:1335–40.
Sinha S, Bastin ME, Whittle IR, et al. AJNR Am J Neuroradiol 2002;23:520–7.
Castillo M, Smith JK, Kwock L, et al. AJNR Am J Neuroradiol 2001;22:60–4.
Stadnik TW, Chaskis C, Michotte A, et al. AJNR Am J Neuroradiol 2001;22:969–76.
Provenzale JM, McGraw P, Mhatre P, et al. Radiology 2004;232:451–60.
Field AS, Alexander AL. Top Magn Reson Imaging 2004;15:315–24.
Dong Q, Welsh RC, Chenevert TL, et al. J Magn Reson Imaging 2004;19:6–18.
Le Bihan D, Douek P, Argyropoulou M, et al. Top Magn Reson Imaging 1993;5:25–31.
Tung GA, Evangelista P, Rogg JM, et al. AJR Am J Roentgenol 2001;177:709–12.
Hein PA, Eskey CJ, Dunn JF, et al. AJNR Am J Neuroradiol 2004;25:201–9.
Biousse V, Newman NJ, Hunter SB, et al. J Neurol Neurosurg Psychiatry 2003;74:382–4.
Moffat BA, Chenevert TL, Lawrence TS, et al. Proc Natl Acad Sci U S A 2005;102:5524–9.
Tofts PS. J Magn Reson Imaging 1997;7:91–101.
Jackson A, O’Connor JP, Parker GJ, et al. Clin Cancer Res 2007;13:3449–59.
Wedam SB, Low JA, Yang SX, et al. J Clin Oncol 2006;24:769–77.
Morgan B, Thomas AL, Drevs J, et al. J Clin Oncol 2003;21:3955–64.
Thomas AL, Morgan B, Horsfield MA, et al. J Clin Oncol 2005;23:4162–71.
Mross K, Drevs J, Muller M, et al. Eur J Cancer 2005;41:1291–9.
Liu G, Rugo HS, Wilding G, et al. J Clin Oncol 2005;23:5464–73.
Galbraith SM, Maxwell RJ, Lodge MA, et al. J Clin Oncol 2003;21:2831–42.
Anderson HL, Yap JT, Miller MP, et al. J Clin Oncol 2003;21:2823–30.
Mayr NA. Yuh WT, Zheng J, et al. AJR Am J Roentgenol 1998;170:177–82.
Law M, Oh S, Johnson G, et al. Neurosurgery 2006;58:1099–107.
Mueller-Lisse UG, Swanson MG, Vigneron DB, et al. Magn Reson Med 2001;46:49–57.
Gleave ME, Goldenberg SL, Jones EC, et al. J Urol 1996;155:213–9.
Pickett B, Kurhanewicz J, Coakley F, et al. Int J Radiat Oncol Biol Phys 2004;60:1047–55.
Castillo M. AJNR Am J Neuroradiol 2001;22:597–8.
Kwock L, Smith JK, Castillo M, et al. Technol Cancer Res Treat 2002;1:17–28.
Smith JK, Castillo M, Kwock L. Magn Reson Imaging Clin N Am 2003;11:415–29, v-vi.
Vuori K, Kankaanranta L, Hakkinen AM, et al. Radiology 2004;230:703–8.
De Stefano N, Bartolozzi ML, Guidi L, et al. J Neurol Sci 2005;233:203–8.
Croteau D, Scarpace L, Hearshen D, et al. Neurosurgery 2001;49:823–9.
Butteriss DJ, Ismail A, Ellison DW, et al. Br J Radiol 2003;76:662–5.
Chang YW, Yoon HK, Shin HJ, et al. M. Pediatr Radiol 2003;33:836–42.
Krieger MD, Panigrahy A, McComb JG, et al. Neurosurg Focus 2005;18, E4.
Kamada K, Houkin K, Abe H, et al. Neurol Med Chir (Tokyo) 1997;37:250–6.
Weybright P, Sundgren PC, Maly P, et al. AJR Am J Roentgenol 2005;185:1471–6.
Turner CD, Chi S, Marcus KJ, et al. J Neurooncol 2007;82:95–101.
Murphy PS, Viviers L, Abson C, et al. Br J Cancer 2004;90:781–6.
Patankar TF, Haroon HA, Mills SJ, et al. AJNR Am J Neuroradiol 2005;26:2455–65.
McKnight TR, Lamborn KR, Love TD, et al. J Neurosurg 2007;106:660–6.
Wester HJ. Clin Cancer Res 2007;13:3470–81.
Francis DL, Visvikis D, Costa DC, et al. J. Eur J Nucl Med Mol Imaging 2003;30:988–94.
Sun H, Sloan A, Mangner TJ, et al. Eur J Nucl Med Mol Imaging 2005;32:15–22.
Nunez R, Macapinlac HA, Yeung HW, et al. J Nucl Med 2002;43:46–55.
Hara T, Kosaka N, Kishi H. J Nucl Med 1998;39:990–5.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, Totowa, NJ
About this chapter
Cite this chapter
Kundra, V., Schellingerhout, D., Jackson, E. (2008). Targeted and Functional Imaging. In: Kurzrock, R., Markman, M. (eds) Targeted Cancer Therapy. Current Clinical Oncology™. Humana Press. https://doi.org/10.1007/978-1-60327-424-1_17
Download citation
DOI: https://doi.org/10.1007/978-1-60327-424-1_17
Publisher Name: Humana Press
Print ISBN: 978-1-60327-423-4
Online ISBN: 978-1-60327-424-1
eBook Packages: MedicineMedicine (R0)